Study Title and Description
Multicenter, randomized study of the use of everolimus with tacrolimus after renal transplantation demonstrates its effectiveness.
Key Questions Addressed
|3||In adult renal transplants, how do immunosuppressive regimens designed to reduce or eliminate exposure to CNI toxicity compare with each other and with full-dose CNI regimens for health outcomes? AND How does the type of induction agent (including when no induction is used) and the use of concurrent immunosuppressive agents affect outcomes of regimens that reduce or eliminate CNI exposure?|
Primary Publication Information
|Title||Multicenter, randomized study of the use of everolimus with tacrolimus after renal transplantation demonstrates its effectiveness.|
|Author||Chan L., Greenstein S., Hardy MA., Hartmann E., Bunnapradist S., Cibrik D., Shaw LM., Munir L., Ulbricht B., Cooper M.|
|Country||Health Sciences Center, University of Colorado, Denver, CO 80262, USA. email@example.com|
Pubmed ID: 18360262
Secondary Publication Information
There are currently no secondary publications defined for this study.
Extraction Form: Comparative Effectiveness of Regimens
Results & Comparisons
No Results found.